Contact Us
search Contact Us 1.800.768.4026

We are accepting new cases

Diabetes Lawsuits /
Ozempic /
Gastroparesis Lawsuit

Gastroparesis Lawsuit

People are filing gastroparesis lawsuits after developing stomach paralysis while using GLP-1 drugs like Ozempic®, Wegovy® and Mounjaro™.

Connect with an attorneyCheck Eligibility
Share
Written by:
Grace Chandler
Associate

Practice areas:Diabetes Lawsuit, Medical Device Lawsuits, Medical Drugs

Grace Chandler advocates for people who have suffered severe, life-altering health complications caused by dangerous and defective medical devices.

Read Full Bio
Last Updated:August 24, 2026
Indicates required field

Connect with a Gastroparesis Lawsuit attorney

This form will help you get in touch with our staff about Gastroparesis Lawsuit. If you have any questions, please complete this form or call 1.800.768.4026. Not the case you were looking for? Start a new form here.

  1. 1 Contact Information Tell us about yourself.

  2. 2 Case Details What should we know about your case?

  3. 3 Completion Thank you for reaching out!

Next

The Legal Team

View Other Attorneys

Case Overview

People are filing gastroparesis lawsuits after using GLP-1 drugs like Ozempic, Wegovy and Mounjaro. Some patients taking these drugs experienced serious and unexpected side effects, including gastroparesis (or stomach paralysis). If you have taken a diabetes or weight-loss drug and experienced these issues, you may be eligible for a gastroparesis lawsuit.

On this Page

See MoreSee Less

Working with Us

Wondering what happens when you submit a form or give us a call? We spend time gathering information from you, and your initial call is always free.

What's important?
  • Names
  • Dates
  • Timeline of events
  • Related documents
Connect with Us

or call: 1.800.768.4026

Important gastroparesis lawsuit updates

  • May 2025: More than 1,800 lawsuits were consolidated in In re: Glugagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation, MDL No. 3094.
  • December 2024: The GLP-1 RA multidistrict litigation (MDL) will not include deep vein thrombosis (DVT) and blood clot injury cases. Motley Rice will aggressively represent individuals suffering these conditions. If you took a GLP-1 RA and developed a DVT, contact a Motley Rice attorney to better understand your options.
  • November 2024: The warning labels on GLP-1 diabetes and weight loss drugs (Ozempic, Wegovy, Rybelsus®, Saxenda®, Victoza®, Mounjaro, Zepbound®) were updated. They now include warnings for pulmonary aspiration during general anesthesia or deep sedation.
  • May 2024: Motley Rice attorney Jonathan Orent was appointed Co-Lead Counsel and Motley Rice attorney Sara Couch was appointed Chair of Marketing Discovery. Both are on the Plaintiffs’ Executive Committee for the Ozempic multidistrict litigation (MDL).

Key takeaways about legal claims for gastroparesis

  • Gastroparesis reduces or completely stops stomach motility.
  • Medications like Ozempic, Wegovy, Rybelsus and Mounjaro have allegedly been linked to gastroparesis and other severe gastrointestinal issues.
  • If you’ve developed gastroparesis after taking certain medications, you may be eligible to file a lawsuit.

What is gastroparesis (stomach paralysis)?

Gastroparesis is a condition affecting the muscles of the stomach. A correctly functioning stomach has strong muscles that move food through the digestive tract. This movement is called “motility.” Gastroparesis affects these muscles and reduces or completely stops motility.

This condition is also called “stomach paralysis” and “delayed gastric emptying."

Gastroparesis has no cure. But doctors may recommend diet changes and medication to help manage the condition.

Gastroparesis has allegedly been linked to certain drugs used to treat type 2 diabetes or as weight-loss aides, including Ozempic and Wegovy. The prescribing labels for these drugs do not adequately warn patients of these potential dangers. Thousands of patients have reported health problems to the U.S. Food and Drug Administration (FDA) after taking these drugs. 

People who have experienced stomach paralysis after taking these medications are now filing gastroparesis lawsuits.

Drugs named in gastroparesis lawsuits

Many plaintiffs allege they developed gastroparesis and other severe gastrointestinal issues after taking GLP-1 RA medications including:

Drug name

Active ingredient

Ozempic

Semaglutide

Rybelsus

Semaglutide

Wegovy

Semaglutide

Mounjaro

Tirzepatide

Zepbound

Tirzepatide

 

Who are the named defendants in gastroparesis lawsuits?

Drug manufacturers Novo Nordisk and Eli Lilly are named defendants in gastroparesis lawsuits.

Novo Nordisk is a global healthcare company. It develops treatments for diseases like diabetes and obesity. This company makes Ozempic, Rybelsus and Wegovy. 

Eli Lilly is a medicine company that develops and manufactures various pharmaceutical products. This company makes Mounjaro and Zepbound.

Who is eligible to file a gastroparesis lawsuit?

People who have developed gastroparesis with severe symptoms as a result of taking a prescribed GLP-1 RA medication may be eligible to file a lawsuit against the drug manufacturer. They must show that they followed the instructions as directed for the drug. And they must prove a clear link between the medication they took and when the gastroparesis symptoms began.

It can be challenging to figure out if you are eligible to file a gastroparesis lawsuit. In that case, explaining your specific situation to a legal professional may help. Consider talking with a lawyer to explore all your potential legal options.

Contact a GLP-1 RA attorney

If you or a loved one has suffered from a serious side effect that wasn't on the label of a GLP-1 RA drug, you may be eligible to file a lawsuit.

Contact us today

You can also reach our team by calling 1.800.768.4026.

Who can file a GLP-1 RA lawsuit? Individuals, or their loved ones, who suffered serious medical conditions after taking a branded GLP-1 RA drug prescribed by a doctor may be eligible to file a lawsuit. The condition must not have been on the drug’s warning label at the time of prescription.

Conditions that may be grounds for a lawsuit include:

  • Vision loss or changes
  • Ileus and intestinal blockages
  • Necrotizing pancreatitis
  • Pulmonary embolisms
  • Deep vein thrombosis (DVT)
  • Gastric distress including severe or permanent stomach paralysis
  • Surgical complications

Frequently asked questions about gastroparesis

Answers to common questions about gastroparesis and related lawsuits are discussed below.

What are the common symptoms of gastroparesis?

Gastroparesis causes food to remain in the stomach for long periods of time. This condition can lead to symptoms like:

  • Abdominal pain and bloating
  • Acid reflux, including heartburn
  • Feeling full after consuming only a small amount of food
  • Feeling full for a long time after consuming a meal
  • Loss of desire to eat
  • Nausea
  • Problems with blood sugar levels
  • Problems with nutrition, including malnutrition
  • Stomach pain, sometimes severe
  • Vomiting, including severe vomiting

If you think you’re experiencing any of these symptoms, please consult with your doctor.

How much will lawsuits related to gastroparesis pay out?

The payout amount awarded from a gastroparesis lawsuit can vary depending on many factors. This includes the severity of the plaintiff’s medical condition and the medical costs to treat it. They also look at how their condition is impacting their quality of life and ability to work.

There is no guarantee that a lawsuit will result in monetary compensation and, if successful, there is no way to know exactly how much you could receive in a lawsuit payout. Consider discussing your specific situation with a lawyer to figure out your legal options.

Why are GLP-1 RA drugs leading to gastroparesis lawsuits?

GLP-1 receptor agonist drugs Ozempic and Mounjaro were developed to help diabetic patients lower their blood sugar levels. Wegovy was developed to help with weight loss. 

These and other GLP-1 RA drugs have grown in popularity as a weight-loss aid over the last several years. Plaintiffs allege this has exposed more people to potentially dangerous side effects (like gastroparesis). Some medication users are filing lawsuits against diabetes and weight loss drug manufacturers. These lawsuits claim the manufacturers didn’t adequately warn patients of the potential dangers.

Our medical drug litigation experience

Our medical attorneys have represented thousands of patients seriously hurt by dangerous prescription and over-the-counter drugs. We understand that as a patient or family member, you may not know much about your or a loved one’s medications.

If you believe a medicine made you sick or hurt you, our attorneys have the resources needed to thoroughly investigate. They can:

  • Identify potentially harmful medicines
  • Investigate how the medicine may have hurt you
  • Review the medicine manufacturer’s compliance with FDA regulations
  • Analyze the effectiveness of the manufacturer’s warning about potential side effects
  • Recognize other issues that could affect your potential claim

Learn more about our medical drug experience here.

Don’t stop taking a prescribed medication without first consulting with your doctor. Stopping a prescribed medication without your doctor's advice can result in injury or death. Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Saxenda, and Victoza are still approved by the U.S. Food and Drug Administration.

What is gastroparesis (stomach paralysis)?

Drugs named in gastroparesis lawsuits

Who is eligible to file a gastroparesis lawsuit?

Frequently asked questions about gastroparesis

Our medical drug litigation experience

About the Author

Grace P. Chandle

Grace P. Chandler

Associate

Grace Chandler advocates for people who have suffered severe, life-altering health complications caused by dangerous and defective medical devices.

Sources
  1. Cleveland Clinic. GLP-1 Agonists.
  2. CNBC. Eli Lilly & Co.
  3. Mayo Clinic. Gastroparesis.
  4. National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Gastroparesis.
  5. U.S. Food and Drug Administration. HIGHLIGHTS OF PRESCRIBING INFORMATION: MOUNJARO™ (tirzepatide) Injection, for subcutaneous use.
  6. U.S. Food and Drug Administration. HIGHLIGHTS OF PRESCRIBING INFORMATION: OZEMPIC (semaglutide) injection, for subcutaneous use.
  7. U.S. Food and Drug Administration. HIGHLIGHTS OF PRESCRIBING INFORMATION: RYBELSUS (semaglutide) tablets, for oral use.
  8. U.S. Food and Drug Administration. HIGHLIGHTS OF PRESCRIBING INFORMATION: WEGOVY (semaglutide) injection, for subcutaneous use.
  9. U.S. Food and Drug Administration. SAXENDA (liraglutide [rDNA origin] injection), solution for subcutaneous use.
Your Legal Options

Start Your Motley Rice Consultation in Simple Steps

Connect with an Attorney1.800.768.4026

1

Submit Information

Call us or fill out our online form with the details of your potential case.

2

Case Review

Our team reviews your information to assess your potential case.

3

Case Consultation

Talk with us about next steps.